Olopatadine Hydrochloride
Product Images NDC 53002-0510

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Olopatadine Hydrochloride (NDC 53002-0510). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Structure (7f1d4519 4ff2 48f5 82ef 61c071667985 01)

Chemical structure diagram of the active ingredient Olopatadine Hydrochloride, showing its molecular configuration with labeled atoms and functional groups.*

FDA Label Image

Label Image (Lbl530020510)

OLOPATADINE HYDROCHLORIDE 0.1% ophthalmic solution in a 5 mL bottle, labeled by RPK Pharmaceuticals, Inc. The label indicates a dosage of 1 drop into affected eye(s) twice daily at a 6-8 hour interval. The label includes spaces for lot number, expiration date, patient name, and clinic information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.